Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HERBAL STERITE PRODUCT WHICH REDUCES THE NUMBER OF AIDSVIRUSES AND ACTIVATES IMMUNITY SYSTEM
Document Type and Number:
WIPO Patent Application WO/2012/055422
Kind Code:
A1
Abstract:
All compound ingredients are prepared from the previous started plants where it has to be dried and it is grinded in a sterilized grinding machine until it became very fine, after that it is mixed together very well, then pasteurized. After grinding, the plants are exposed to a heat of 65 centigrade in a double water basin for a half hour approximately, then it is called quickly to a heat of -20 centigrade for two hours, and after the pasteurization process it is filled in capsules. The Shaba'a Alumn is excluded from the pasteurization process.

Inventors:
ABUHJEELEH MOHAMMAD FLIEH QABLAN (EG)
QURAISH HUSSEIN MOHAMMAD AHMAD (EG)
Application Number:
PCT/EG2011/000007
Publication Date:
May 03, 2012
Filing Date:
April 18, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ABUHJEELEH MOHAMMAD FLIEH QABLAN (EG)
QURAISH HUSSEIN MOHAMMAD AHMAD (EG)
International Classes:
A61K36/54; A61K36/185; A61K36/57; A61K36/71; A61K36/889; A61K36/8905; A61K36/9062; A61K36/9066; A61K36/9068
Domestic Patent References:
WO2005030232A22005-04-07
Foreign References:
US20070036834A12007-02-15
Other References:
DATABASE WPI Week 200922, Derwent World Patents Index; AN 2009-E71879, XP002643389
DATABASE TCM [online] SIPO; 15 April 1998 (1998-04-15), LUO MENG: "Oral liquid for treatment of AIDS and process for preparation thereof", XP002643390, Database accession no. CN-97119122-A
KUSUMOTO I T ET AL: "SCREENING OF VARIOUS PLANT EXTRACTS USED IN AYURVEDIC MEDICINE FOR INHIBITORY EFFECTS ON HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) PROTEASE", PHYTOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, vol. 9, no. 3, 1 May 1995 (1995-05-01), pages 180 - 184, XP001087900, ISSN: 0951-418X
EL-MEKKAWY S ET AL: "INHIBITORY EFFECTS OF EGYPTIAN FOLK MEDICINES ON HUMAN IMMUNODEFICIENCY VIRUS (HIV) REVERSE TRANSCRIPTASE", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, vol. 43, no. 4, 1 April 1995 (1995-04-01), pages 641 - 648, XP000196426, ISSN: 0009-2363
RUNYORO ET AL: "Medicinal plants used by Tanzanian traditional healers in the management of Candida infections", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 106, no. 2, 30 June 2006 (2006-06-30), pages 158 - 165, XP005456424, ISSN: 0378-8741, DOI: DOI:10.1016/J.JEP.2005.12.010
DUGOUA J-J: "From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark", CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 200709 CA LNKD- DOI:10.1139/Y07-080, vol. 85, no. 9, September 2007 (2007-09-01), pages 837 - 847, XP009149536, ISSN: 0008-4212
MOHAMED BASTWAY: "Protective effects of extract from dates (Phoenix dactylifera L.) and Ascorbic acid on Thioacetamide-induced Hepatotoxicity in Rats", IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, vol. 7, no. 3, July 2008 (2008-07-01), pages 193 - 201, XP009149560, ISSN: 1735-0328
Download PDF:
Claims:
Claims

5) The new elements to be protected

All the formulation's ingredients made of plants. All to be mentioned here under along with their rates and methods of preparation.

The plants are :-

1. Ginger 50 gram

2. Pimpinella Anisum L. 50 gram

3. Shaba" a Alumn 25 gram

4. Pahoenix Dactylifera L. 100 gram

5. Galingale Alpinia Galangae 50 gram

6. Cinnamon Laurus cassia 50 gram

7. Balanites Aegyptiaca L. 50 gram

8. Curcuma long Durouma lcnoa 50 gram

9. Nigella Sativa 100 gram

10. Cyperus rotundus 50 gram

new

elements to be protected

All the ingredients of the formulation , including the plants, their percentages and preparation methods

How to prepare the compound ( The Invention)

Description:
HERBAL STERITE PRODUCT WHICH REDUCES THE NUMBER OF AIDSVIRUSES AND

ACTIVATES IMMUNITY SYSTEM

Technical field

1. Reducing Viral Load for HIV-1 , HCV and HBV.

2. Increasing CD4 AND CD8 .

3. Activating Immunosystem.

Background Art

There is no Background Art

Disclosure of The Invention

(Including the mode of operation in the cases of devices, tools, equipments or chemical preparation in the cases of chemical and agricultural materials, practical experiments, and aside effects and tables, and illustrated drawing' panels- if there is - in independent pages after new elements that its protection are required, provided that the drawings are numbered, in vertical position and there is no any shown data on it, and parts of the drawing are defined with numbers to be illustrated and explained inside the detailed description)

antibiotic and

germs as well.

50 Tonic and Contains volatile The seeds gram activated for oil most of it's

Pimpinella

intestine and ingredients ,

Anisum L.

killer for bacteria anathema

and increase mythical Nicola

famine Estrogen in addition to

Harmony protean, fats &

excretion carbohydrate

Shaba'a Alumn 25 Sterilized, Salts resiting The Shaba'as gram disinfected and viruses and stone is milled antibiotic for bacteria , and it

germs and is a group of

bacteria compound salts

Cinnamon 50 Tonic for Elusionol ( The Bark/The

Laurus cassia gram stomach, liver Elusionic peel

and strengthen Acide)

for blood and , pines ,ben

vision as well deheed, aldheed

cosmic

Balanites 50 Virus copy killer Contains The seeds

Aegyptiaca L. gram , malaria killer , saboneen,

disinfectant and estroneedeya,

remedy for calcbojene

abscess and alba compounds ,

neutigene,

protein, sugar,

vitamin and

mineral salts

100 Treating knoll , Contains volatile The seeds gram alba and abscess oil, most of its

shown on the ingridents,

Nigella Sativa

skin, open neglin, alinglen,

blockage in the themohydrokene

liver , good en

jaundice ,

activating the

bladder, liver and

tonic for the

stomach wall and

intestine ,

expanding

arteries, fungal and viruses killer

Le Curcuma 50 Treating the alba Fixed oilcalled The trunk long gram , jaundice , wipe termorool and

Durouma lcnoa the abscess , colored item

strengthen the called

vision and fungus carcumeen

killer

50 Activate , volatile oil The branch gram stimulant for the

Galingale contains of

human being effectgive

Alpinia

immunity system material such as

Galangae

and bacteria and senoil, methal

stomach viruses ceinmat and

expeller , useful reezomat

for coughing and contains of

angina pectoris starchy and

ratingat

contgains of

galingol,

camfreed,

galingeen, and

one ether al- meethal from

galgengin

Pahoenix 100 Tonic for Sugarcane , Powder Dactylifera L. gram stomach, protein, calcium, accumulated on intestines , vitamins, the male palm stimulate for minerals such as

blood, and iron phosphor

strengthen for the and contains a

body because of quantity of

lot of fatty starchy materials

material, active

for immunity

system, and

strengthen for

vision and audio

nerves, and

soften the blood

because it

contains the

routine material

and material for

power and movement

Cyperus 50 For treating the Glocose, frektoz, The roots rotundus gram gum abscess, and heart glucose

activating the starchy ,

blood circle and alkaline, gall oak

tonic for the body material, vitamin

and sterilizing and bitter

the stomach material

Brief

EZl G i n g e r 5 0 g r a m

MM P im p i n e 11 a 5 0 g

□ S h a b a ' a 2 5 g

ΠΏ C in n a m o n 5 0 g

■■ B a la n ite s 5 0 g

1— 1 N i g e 11 a 1 0 0 g

mm L e C u c u m a 5 0 g

ΠΠ G a lin g a le S 0 g

■1 P a h o e n ix l O O g

Hi C y p e r u s 5 0 g

The important sickness that responded with the compound :

1 - The gained immunity shortage virus Aids

2- Hepatitis Virus (HBV)

3- Hepatitis Virus (HCV)

Method of using the compound:

1- A blood sample is taken from the blood to conduct a laboratory test for the patient before using the compound to find out the number of the virus copy upon the patient.

After finding out the number of the virus copies upon the patient , he is given one capsule in the morning and one capsule in the afternoon from the compound, after that , a blood sample is taken from the patient after

30 days from using the compound to conduct a laboratory test to show the result